Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
11/2002
11/28/2002WO2002094826A1 Tri-and tetraaza-acenaphthylen derivatives as crf receptor antagonists
11/28/2002WO2002094825A1 Novel spiropiperidine derivative
11/28/2002WO2002094823A1 1-biaryl-1,8-napthyridin-4-one phosphodiesterase-4 inhibitors
11/28/2002WO2002094821A1 Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same
11/28/2002WO2002094813A1 Novel pyridyl cyanoguanidine compounds
11/28/2002WO2002094812A1 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/28/2002WO2002094811A1 4-(penyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/28/2002WO2002094810A1 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/28/2002WO2002094808A1 Imidazole-2-carboxamide derivatives as raf kinase inhibitors
11/28/2002WO2002094802A1 Substituted c-furan-2-yl-methylamine and c-thiophen-2-yl-methylamine derivatives
11/28/2002WO2002094795A1 4-aminopyrimidine derivatives
11/28/2002WO2002094794A1 4 (phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain anxiety or gastrointestinal disorders
11/28/2002WO2002094786A1 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain anxiety or gastrointestinal disorders
11/28/2002WO2002094785A1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/28/2002WO2002094784A1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/28/2002WO2002094783A1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/28/2002WO2002094782A1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derativatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/28/2002WO2002094376A2 Compositions and methods for promoting or inhibiting ndpk
11/28/2002WO2002094319A1 Preventive or recurrence-suppressive agents for liver cancer
11/28/2002WO2002094296A1 Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative bacteria, potential pathogenic gram-positive bacteria
11/28/2002WO2002094289A1 Antiviral nucleoside derivatives
11/28/2002WO2002094274A1 Cathartic composition
11/28/2002WO2002094270A2 Mip-1 alpha receptor ligands - drugs for t-cell mediated and autoimmune diseases
11/28/2002WO2002094263A2 Caspase inhibitors and uses thereof
11/28/2002WO2002094221A1 Emulsion and dispersion formulations and method
11/28/2002WO2002094220A1 Liquid pharmaceutical composition
11/28/2002WO2002094204A1 Dental restorative materials
11/28/2002WO2002094203A2 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
11/28/2002WO2002094202A2 Methods for protecting allogeneic islet transplant using soluble ctla4 mutant molecules
11/28/2002WO2002094193A1 Methods for inhibiting angiogenesis
11/28/2002WO2002094192A2 Antibodies against tumor necrosis factor delta (april)
11/28/2002WO2002094187A2 Novel use
11/28/2002WO2002094180A2 Pharmaceutically active isoindoline derivatives
11/28/2002WO2002094019A1 Highly purified antiendotoxin compound
11/28/2002WO2002085897A8 Heterocyclic compounds for aging-related and diabetic vascular complications
11/28/2002WO2002080887A3 Timed pulse release composition
11/28/2002WO2002079408A3 Short bioactive peptides and methods for their use
11/28/2002WO2002078616A3 Methods for increasing serotonin levels by administering (-)-hydroxycitric acid
11/28/2002WO2002072631A8 Mhc molecule constructs and their usesfor diagnosis and therapy
11/28/2002WO2002070563A3 Nuclear hormone receptor ligand binding domain
11/28/2002WO2002047711A3 Modulators of activity of g-protein-coupled receptor kinases
11/28/2002WO2002044153A8 4-6-diphenyl pyridine derivatives as antiinflammatory agents
11/28/2002WO2002035235A3 Net as regulator of angiogenic expression
11/28/2002WO2002024924A3 Protein phosphatases
11/28/2002WO2002020002A3 A method for treating allergies
11/28/2002WO2002008255A3 Cell cycle proteins and mitosis-associated molecules
11/28/2002WO2001098360A3 Gp354 nucleic acids and polypeptides
11/28/2002WO2001081415A3 Parathyroid hormone and parathyroid hormone-related protein antagonists
11/28/2002WO2001018021A9 B7-like polynucleotides, polypeptides, and antibodies
11/28/2002US20020178459 Genetically engineered mammal for use in the treatment of muscle and liver disorders
11/28/2002US20020177706 Rheumatic diseases; antiarthritic agents; antitumor agents
11/28/2002US20020177626 Comprises analgesics such as ibuprofen and diphenhydramine; storage stability
11/28/2002US20020177618 ERK (extracellular signal regulated kinase) inhibitors for treatment of cancer, inflammatory disorders, restenosis, and cardiovascular disease
11/28/2002US20020177609 Fatty alcohol drug conjugates
11/28/2002US20020177605 3-substituted isoquinolin-1-yl derivatives
11/28/2002US20020177601 Inhibit the signal transduction by tyrosine kinases; e.g. 4-(3-chloro-4-fluorophenylamino)-6-(3-(4-(methoxycarbonyl-methyl)-1 -piperazinyl)propyloxy)-7-methoxyquinazoline; use such as antitumor agent
11/28/2002US20020177591 Central nervous system (CNS); diazabicyclo compounds such as 1,4-Diaza-bicyclo(3.2.2)nonane-4-carboxylic acid, 4-cyclohexyl-phenyl ester; CNS-penetrant alpha 7 nicotinic receptor agonist
11/28/2002US20020177587 Treating sexual dysfunction including erectile dysfunction, diabetes melitus, gastrointestinal disorders, including gastric paresis and cardiovascular disorders; cyclic guanosine 3',5'-monophosphate (cGMP)
11/28/2002US20020177586 Method for treating fibrotic diseases or other indications ID
11/28/2002US20020177213 Tissue plasminogen activator-like protease
11/28/2002US20020176911 Includes xanthan gum which improves tolerance (e.g. less gastrointestinal symptoms such as emesis, stool patterns and gas)
11/28/2002US20020176888 Oral dosage forms
11/28/2002US20020176887 Methods of delivery of cetyl myristoleate
11/28/2002US20020176885 Given concentration of halide-comprising salts such as sodium chloride; nonirritating antiseptic; can be used in eyes
11/28/2002US20020176881 Rehydration composition
11/28/2002US20020176868 Isolation and characterization of the csa operon (ETEC-CS4 pili) and methods of using same
11/28/2002US20020176827 Carrier and composition comprising polybutene with molecular weight of 300-3000 and one or more cosmetic or therapeutic actives, releasably associated to carrier
11/28/2002DE10125145A1 New C-furanyl- or C-thienyl-methylamine derivatives, useful e.g. for treating arrhythmia, emesis, inflammation, cardiovascular or neurodegenerative disease, asthma, glaucoma or especially pain
11/28/2002DE10122140A1 Rekombinante Fusionsproteine und deren Trimere Recombinant fusion proteins and their trimers
11/28/2002CA2450535A1 Tri-and tetraaza-acenaphthylen derivatives as crf receptor antagonists
11/28/2002CA2447942A1 A gene and uses therefor
11/28/2002CA2447338A1 Receptors and membrane-associated proteins
11/28/2002CA2447231A1 Methods for inhibiting angiogenesis
11/28/2002CA2447170A1 Emulsion and dispersion formulations and method
11/28/2002CA2447103A1 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
11/28/2002CA2447063A1 Novel use
11/28/2002CA2447020A1 The use of 4-aminopyridine derivatives for the treatment of mglur5 receptor mediated diseases
11/28/2002CA2446734A1 Antibodies against tumor necrosis factor delta (april)
11/28/2002CA2446516A1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/28/2002CA2446332A1 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/28/2002CA2446331A1 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/28/2002CA2446316A1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/28/2002CA2446313A1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/28/2002CA2446311A1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derativatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/28/2002CA2446155A1 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain anxiety or gastrointestinal disorders
11/28/2002CA2446154A1 4-(penyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/28/2002CA2445631A1 Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same
11/28/2002CA2444955A1 Inactivation of genes of the mep pathway
11/28/2002CA2441801A1 Methods and formulations for increasing the affinity of a1 adenosine receptor ligands for the a1 adenosine receptor
11/28/2002CA2427619A1 Pharmaceutically active isoindoline derivatives
11/27/2002EP1260587A2 Tyrosyl tRNA synthetase
11/27/2002EP1260512A1 Novel cyclic amide derivatives
11/27/2002EP1260227A1 Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative bacteria, potential pathogenic gram-positive bacteria
11/27/2002EP1259621A2 Lipid metabolism enzymes
11/27/2002EP1259615A1 Human antibodies against eotaxin and their use
11/27/2002EP1259612A2 G-protein coupled receptor related polypeptides
11/27/2002EP1259611A2 G-protein coupled receptors
11/27/2002EP1259595A2 Integrin antagonists
11/27/2002EP1259544A2 Heterologous polypeptide of the tnf family
11/27/2002EP1259527A1 35 human secreted proteins
1 ... 922 923 924 925 926 927 928 929 930 931 932 933 934 935 936 937 938 939 940 941 942 ... 1258